Bryan T. Vaughn, EVP and President, Diagnostics at Labcorp Holdings Inc. (NYSE:LH), filed a Form 4 on November 3, 2026, reporting the vesting of 500 restricted stock units and a subsequent share withholding transaction on November 1-2, 2026.
Key Highlights
- RSU vesting: 500 restricted stock units vested on November 1, 2026, with each unit representing the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
- Shares withheld for taxes: 194 shares were disposed of on November 2, 2026, at $355.59 per share to satisfy tax withholding obligations.
- Resulting direct ownership: Following the transactions, Vaughn directly held 7,150.9105 shares of Common Stock.
- ESPP shares included: The total share count includes 99.3403 shares acquired on June 30, 2026 under the Labcorp Holdings Inc. 2025 Employee Stock Purchase Plan.
- Remaining RSUs: Vaughn held 4,704 restricted stock units in aggregate following the reported transactions.
- Filing signed: The form was signed by Kathryn W. Kyle, Attorney-in-Fact for Bryan T. Vaughn, on November 3, 2026.
Vaughn RSU Vesting and Tax Withholding Details at Labcorp
According to the Form 4 filed with the SEC, Bryan T. Vaughn, serving as EVP and President, Diagnostics at Labcorp Holdings Inc. (NYSE:LH), reported two transactions in the company's common stock over consecutive days. On November 1, 2026, 500 restricted stock units converted to common stock under transaction code M, representing a vesting event. The filing notes that each restricted stock unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock, and the units vested on November 1, 2026.
On November 2, 2026, the filing reports a disposition of 194 shares at a price of $355.59 per share under transaction code F. The filing identifies this as stock withholding to satisfy tax withholding obligations. Following both transactions, Vaughn's direct beneficial ownership of common stock stood at 7,150.9105 shares, a figure that the filing states includes 99.3403 shares acquired on June 30, 2026 under the Labcorp Holdings Inc. 2025 Employee Stock Purchase Plan.
In Table II, covering derivative securities, the filing records that Vaughn held 4,704 restricted stock units in aggregate after the reported transaction, all held directly. The RSUs had a derivative security price of $0 and no expiration date listed beyond the November 1, 2026 vesting date associated with the 500 units that converted. The filing was submitted by Kathryn W. Kyle as Attorney-in-Fact for Bryan T. Vaughn on November 3, 2026.
What Was Disclosed
This Form 4 discloses the November 1, 2026 vesting of 500 RSUs held by Labcorp EVP Bryan T. Vaughn, followed by the withholding of 194 shares at $355.59 on November 2, 2026 for taxes, leaving him with 7,150.9105 shares of common stock and 4,704 remaining RSUs.



Please wait processing your request...